Oltra, S.S.; Cejalvo, J.M.; Tormo, E.; Albanell, M.; Ferrer, A.; Nacher, M.; Bermejo, B.; Hernando, C.; Chirivella, I.; Alonso, E.;
et al. HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women. Cancers 2020, 12, 412.
https://doi.org/10.3390/cancers12020412
AMA Style
Oltra SS, Cejalvo JM, Tormo E, Albanell M, Ferrer A, Nacher M, Bermejo B, Hernando C, Chirivella I, Alonso E,
et al. HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women. Cancers. 2020; 12(2):412.
https://doi.org/10.3390/cancers12020412
Chicago/Turabian Style
Oltra, Sara S., Juan Miguel Cejalvo, Eduardo Tormo, Marta Albanell, Ana Ferrer, Marta Nacher, Begoña Bermejo, Cristina Hernando, Isabel Chirivella, Elisa Alonso,
and et al. 2020. "HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women" Cancers 12, no. 2: 412.
https://doi.org/10.3390/cancers12020412
APA Style
Oltra, S. S., Cejalvo, J. M., Tormo, E., Albanell, M., Ferrer, A., Nacher, M., Bermejo, B., Hernando, C., Chirivella, I., Alonso, E., Burgués, O., Peña-Chilet, M., Eroles, P., Lluch, A., Ribas, G., & Martinez, M. T.
(2020). HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women. Cancers, 12(2), 412.
https://doi.org/10.3390/cancers12020412